Management Board - Outcome of written procedures finalised during the period from 29 June to 22 September 2025
Management Board - Outcome of written procedures finalised during the period from 29 June to 22 September 2025
Fasturtec
Ixiaro
Human medicines European public assessment report (EPAR): Duloxetine Viatris (previously Duloxetine Mylan), duloxetine, Date of authorisation: 19/06/2015, Revision: 22, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Zycortal, desoxycortone, Status: Authorised
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 October 2025, 10:00 (CEST) to 20 October 2025, 12:00 (CEST)
Request for veterinary medicinal product classification
Veterinary medicines European public assessment report (EPAR): Zulvac SBV, inactivated Schmallenberg virus, strain BH80/11-4, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Zenalpha, medetomidine hydrochloride,vatinoxan hydrochloride, Status: Authorised